[1]
Choucair*, N., Saker*, Z., Kheir Eddine*, H., Bahmad*, H.F., Fares, Y., Zaarour, M., Harati, H. and Nabha, S. 2022. Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma. Pathologica - Journal of the Italian Society of Anatomic Pathology and Diagnostic Cytopathology. 114, 2 (Apr. 2022), 128-137. DOI:https://doi.org/10.32074/1591-951X-294.